Are the colors and shapes of current psychotropics designed to maximize the placebo response?

Psychopharmacology

Volumn 211, Issue 1, 2010, Pages 113-122

  Khan, Arif ^a,b   Bomminayuni, Eswara Prasad ^a   Bhat, Amritha ^a   Faucett, James ^a   Brown, Walter A ^c,d  

^a Northwest Clinical Research Center   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressant; Antipsychotic; Anxiolytic; Colors; Drug; Placebo response

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPANIC AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; TRANQUILIZER;

ARTICLE; CONTROLLED STUDY; DRUG CAPSULE; DRUG FORMULATION; EXPECTATION; PLACEBO EFFECT; PRIORITY JOURNAL; TABLET;

CENTRAL NERVOUS SYSTEM AGENTS; COLOR; DRUG ADMINISTRATION ROUTES; DRUG PACKAGING; FORMS AND RECORDS CONTROL; HUMANS; PERCEPTION; PLACEBOS; PSYCHOLOGY; PSYCHOPHYSICS; TABLETS;

EID: 77955570395     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1874-z     Document Type: Article

References (19)

1. Adams FM, Osgood CE (1973) A cross-cultural study of the affective meanings of color. J Cross Cult Psychol 4:135-156
2. Blackwell B, Bloomfield SS, Buncher CR (1972) Demonstration to medical students of placebo responses and non-drug factors. Lancet 1:1279-1282
3. Buckalew LW, Coffield KE (1982a) An investigation of drug expectancy as a function of capsule color and size and preparation form. J Clin Psychopharmacol 2:245-248
4. Buckalew LW, Coffield KE (1982b) Drug expectation associated with perceptual characteristics: ethnic factors. Percept Mot Skills 55:915-918
5. de Craen A J M, Roos PJ, de Vries AL, Kleijnen J (1996) Effect of colour of drugs: systematic review of perceived effect of drugs and their effectiveness. BMJ 313:1624-1626
6. Duric VM, Fallowfield LJ, Saunders C, Houghton J, Coates AS, Stockler MR (2005) Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile? Br J Cancer 93:1319-1323
7. Fallowfield F, Atkins L, Catt S et al (2005) Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Ann Oncol 17:205-210
8. Frank JD, Frank JB (1991) Persuasion and healing: a comparative study of psychotherapy. The Johns Hopkins University Press, Baltimore
9. Hussain MZ (1972) Effect of shape of medication in treatment of anxiety states. Br J Psychiatry 120:507-509
10. Jacobs KW, Nordan FM (1979) Classification of placebo drugs: effect of color. Percept Mot Skills 49:367-372
11. Khan A, Kolts RL, Thase ME, Krishnan K R R, Brown W (2004) Research design features associated with the outcome of antidepressant clinical trials. Am J Psychiatry 161:2045-2049
12. Khan A, Kolts RL, Rapaport MH, Krishnan K R R, Brodhead AE, Brown W (2005) Magnitude of placebo response and drug-placebo differences across psychiatric disorders. Psychol Med 35:743-749
13. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M (2002) Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 159:122-129
14. Oken BS (2008) Placebo effects: clinical aspects and neurobiology. Brain 131:2812-2823
15. Thomson Reuters (2009) Physicians' Desk Reference, 63rd edn. Thomson Reuters, Montvale
16. Ridgway D, Khan A, Cierpial MA, Lineberry CG (2007) Subject numbers and placebo outcome variability in clinical trials of new CNS medications. Drug Inf J 41:701-708
17. Rutherford BR, Sneed JR, Roose SP (2009) Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom 78:172-181
18. Sallis RE, Buckalew LW (1984) Relation of capsule color and perceived potency. Percept Mot Skills 58:897-898
19. Schapira K, McClelland HA, Griffiths NR, Newells DJ (1970) Study on the effects of tablet colour in the treatment of anxiety states. BMJ 2:446-449